Polypeptide multilayer nanofilm artificial red blood cells

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 81, Issue 1, 2007, Pages 261-268

  Palath, Naveen ^a   Bhad, Sujaykumar ^a   Montazeri, Reza ^b   Guidry, Christopher A ^b,e   Haynie, Donald T ^a,b,c,d  

^a Artificial Cell Technologies Inc   (United States)

^b Louisiana Tech University   (United States)

^c Louisiana Tech University   (United States)

^d CENTRAL MICHIGAN UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Artificial cell; Blood substitute; Layer by layer assembly; Polypeptide multilayer film; Red blood cell

Indexed keywords

ARTIFICIAL ORGANS; BLOOD; BLOOD SUBSTITUTES; CELLS; ENCAPSULATION; MULTILAYER FILMS; ORGANIC ACIDS; POLYPEPTIDES;

ARTIFICIAL CELL; ETHYLENEDIAMINETETRAACETIC ACID; LAYER BY LAYER ASSEMBLY; VISIBLE WAVELENGTH ABSORBANCE;

NANOSTRUCTURED MATERIALS;

BLOOD SUBSTITUTE; CALCIUM CARBONATE; DEOXYHEMOGLOBIN; EDETIC ACID; HEMOGLOBIN; METHEMOGLOBIN; NANOFILM; OXYGEN; OXYHEMOGLOBIN; POLYGLUTAMIC ACID; POLYLYSINE; POLYPEPTIDE;

ADSORPTION; ANIMAL CELL; ARTICLE; ARTIFICIAL MEMBRANE; ENCAPSULATION; ERYTHROCYTE; FILM; FLUORESCENCE MICROSCOPY; NONHUMAN; OXYGENATION; PH; PROTEIN FUNCTION; SPECTROSCOPY;

ANIMALS; BLOOD SUBSTITUTES; CALCIUM CARBONATE; CAPSULES; CATTLE; ERYTHROCYTES; HEMOGLOBINS; METHEMOGLOBIN; MICROSCOPY, FLUORESCENCE; NANOSTRUCTURES; PEPTIDES; POLYGLUTAMIC ACID; POLYLYSINE;

EID: 33947637888     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30661     Document Type: Article

References (48)

1. Putney SD, Burke PA. Improving protein therapeutics with sustained-release formulations. Nat Biotechnol 1998;16:153-157.
2. Marx V. Business-watching peptide drugs grow up. Chem Eng News 2005;83:17-24.
3. Brown LR. Commercial challenges of protein drug delivery. Expert Opin Drug Deliv 2005;2:29-42.
4. Wei O, Chen H, Jones ML, Metz T, Haque T, Martoni C, Prakash S. Artificial cell microcapsule for oral delivery of live bacterial cells for therapy: Design, preparation, and in-vitro characterization. J Pharm Pharm Sci 2004;7:315-324.
5. Haynie DT, Zhang L, Rudra JS, Zhao W, Zhong Y, Palath N. Polypeptide multilayer films. Biomacromolecules 2006;6:2895-2913.
6. Zhi ZL, Haynie DT. High-capacity functional protein encapsulation in nanoengineered polypeptide microcapsules. Chem Commun 2006;147-149.
7. Zhi ZL, Haynie DT. Straightforward and effective protein encapsulation in polypeptide-based artificial cells. Artif Cells Blood Substit Immobil Biotechnol 2006;34:189-203.
8. Stowell CP, Levin J, Spiess BD, Winslow RM. Progress in the development of RBC substitutes. Transfusion 2001;41:287-299.
9. Squires EJ. Artificial blood. Science 2002;295:1002-1005.
10. Winslow RM. Blood substitutes. Adv Drug Deliv Rev 2000;40:131-142.
11. Moore EE. Blood substitutes: The future is now. J Am Coll Surg 2003;196:1-17.
12. Alayash AI. Oxygen therapeutics: Can we tame haemoglobin? Nat Rev Drug Discov 2004;3:152-159.
13. Chang TMS. Future generations of red blood cell substitutes. J Intern Med 2003;253:527-535.
14. Chang TMS. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov 2005;4:221-235.
15. Kjellström BT. Blood substitutes: Where do we stand today? J Intern Med 2003;253:495-497.
16. Spahn DR. Blood substitutes artificial oxygen carriers: Perfluorocarbon emulsions. Crit Care 1999;3:R93-R97.
17. 2 carriers? Surg Forum 1981;32:299-301.
18. Greenburg G, Kim HW. Hemoglobin-based oxygen carriers. Crit Care 2004;8:S61-S64.
19. Chang TMS, Modified hemoglobin-based blood substitutes: Crosslinked, recombinant and encapsulated hemoglobin. Vox Sang 1998;74:233-241.
20. Phillips WT, Klipper RW, Awasthi VD, Rudolph AS, Cliff R, Kwasiborski V, Goins BA. Polyethylene glycol-modified liposome-encapsulated hemoglobin: A long circulating red cell substitute. J Pharmacol Exp Ther 1999;288:665-670.
21. Chang TMS, Yu WP. Nanoencapsulation of hemoglobin and rbc enzymes based on nanotechnology and biodegradable polymer. In: Chang TMS, editor. Blood Substitutes: Principles, Methods, Products and Clinical Trials. Basel: Karger; 1998. pp 216-231.
22. Her RK. Multilayers of colloidal particles. J Colloid Interface Sci 1966;21:569-594.
23. Decher G. Fuzzy nanoassemblies: Toward layered polymeric multicomposities. Science 1997;277:1232-1237.
24. Decher G. Polyelectrolyte multilayers, an overview. In: Decher G, Schlenoff JB, editors. Multilayer Thin Films: Sequential Assembly of Nanocomposite Materials. Weinheim: Wiley-VCH; 2003. pp 1-46.
25. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P, editors. Molecular Biology of the Cell. New York: Garland Science; 2002.
26. Haynie DT. Physics of polypeptide multilayer films. J Biomed Mater Res B Appl Biomater 2006 Jan. Epub ahead of print.
27. Li B, Haynie DT. Multilayer biomimetics: Reversible covalent stabilization of a nanostructured biofilms. Biomacromolecules 2004;5:1667-1670.
28. Zhang L, Li B, Zhi ZL, Haynie DT. Perturbation of nanoscale structure of polypeptide multilayer thin films. Langmuir 2005;21:5439-5445.
29. Zhong Y, Li B, Haynie DT. Fine tuning of physical properties of designed polypeptide multilayer films by control of pH. Biotechnol Prog 2006;22:126-132.
30. Li B, Rozas J, Haynie DT. Structural stability of polypeptide nanofilms under extreme conditions. Biotechnol Prog 2006;22:111-117.
31. Keller SW, Kim H-N, Mallouk TE. Layer-by-layer assembly of intercalation compounds and heterostructures on surfaces: Towards molecular "beaker" epitaxy. J Am Chem Soc 1994; 116:8817,8818.
32. Caruso F, Trau D, Möhwald H, Renneberg R. Enzyme encapsulation in layer-by-layer engineered multilayer polymer capsules. Langmuir 2000;16:1485-1488.
33. Lvov Y, Antipov AA, Mamedov A, Möhwald H, Sukhorukov GB. Urease encapsulation in nanoorganized microshells. Nano Lett 2001;1:125-128.
34. 3 microparticles templating. Biomacromolecules 2004;5:1962-1972.
35. Dixon HBF, McIntosh R. Reduction of methaemoglobin in haemoglobin samples using gel filtration for continuous removal of reaction products. Nature 1967;213:399,400.
36. Dickerson RE. Hemoglobin: Structure, Function, Evolution, and Pathology, Menlo Park, CA: Benjamin-Cummings; 1983.
37. Wireko FC, Abraham DJ. The crystal state binding of dithionite to deoxy-hemoglobin. Protein Eng 1992;5:3-5.
38. Atamna H, Ginsburg H. Heme degradation in the presence of glutathione. J Biol Chem 1995;270:24876-24883.
39. Guyton AC, Hall JE, editors. Textbook of Medical Physiology. Philadelphia: Saunders; 2000.
40. Lvov Y. Electrostatic layer-by-layer assembly of proteins and polyions. In: Lvov Y, Möhwald H, editors. Protein Architecture: Interfacing Molecular Assemblies and Immobilization Biotechnology. New York: Marcel Dekker; 2000. pp 125-167.
41. Haynie DT, Balkundi S, Palath N, Chakravarthula K, Dave K. Polypeptide multilayer films: Role of molecular structure and charge. Langmuir 2004;20:4540-4547.
42. Zhi Z-I, Haynie DT. Direct evidence of controlled interlayer to intralayer structure reorganization in a nano-organized polypeptide multilayer thin film. Macromolecules 2004;37:8668-8675.
43. Haynie DT, Zhang L, Zhao W, Smith JM. Quantal self-assembly of polymer layers in polypeptide multilayer nano-films. Biomacromolecules, in press.
44. Zheng B, Haynie DT, Zhong H, Sabnis K, Surpuriya V, Pargaonkar N, Sharma G, Vistakula K. Design of peptides for thin films, coatings, and microcapsules for applications in biotechnology. J Biomater Sci Polym Ed 2005;16:285-300.
45. Grant GA, editor. Synthetic Peptides: A User's Guide. New York: Oxford University Press; 2002.
46. Brown TA, editor. Essential Molecular Biology: A Practical Approach. Oxford: Oxford University Press; 2000.
47. Roe S, editor. Protein Purification Techniques: A Practical Approach. Oxford: Oxford University Press; 2001.
48. Haynie DT, Palath N, Liu Y, Li B, Pargaonkar N. Biomimetic nanotechnology: Inherent reversible stabilization of polypeptide microcapsules. Langmuir 2005;21:1136-1138.